Insider: Goff Brian Chief Executive Officer - AGIOS PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 123,528 | 0 | 123,528 |
| Value | $4,522,360.08 | $0.00 | $4,522,360.08 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/08/2025 | DDS | 11,085 | Direct | COM | $36.67 | $406,486.95 | 123,528 |
| 06/24/2025 | DDS | 12,471 | Direct | COM | $33.54 | $418,277.34 | 105,401 |
| 06/24/2025 | DDS | 6,229 | Direct | COM | $33.54 | $208,920.66 | 111,922 |
| 03/03/2025 | DDS | 4,153 | Direct | COM | $35.54 | $147,597.62 | 83,139 |
| 03/03/2025 | DDS | 8,794 | Direct | COM | $35.54 | $312,538.76 | 92,345 |
| 08/08/2024 | DDS | 11,091 | Direct | COM | $42.75 | $474,140.25 | 78,792 |
| 06/05/2024 | DDS | 12,115 | Direct | COM | $48.84 | $591,696.60 | 67,192 |
| 03/05/2024 | DDS | 4,156 | Direct | COM | $32.57 | $135,360.92 | 53,780 |
| 01/24/2024 | DDS | 7,635 | Direct | COM | $21.64 | $165,221.40 | 49,436 |
| 01/09/2024 | DDS | 12,066 | Direct | COM | $22.99 | $277,397.34 | 40,053 |
| 08/08/2023 | DDS | 10,178 | Direct | COM | $25.48 | $259,335.44 | 26,592 |
| 06/30/2023 | DDS | 11,449 | Direct | COM | $28.36 | $324,693.64 | 14,079 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research